Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

Ino de Bruijn(Memorial Sloan Kettering Cancer Center), Ritika Kundra(Memorial Sloan Kettering Cancer Center), Brooke Mastrogiacomo(Memorial Sloan Kettering Cancer Center), Thinh Ngoc Tran(Memorial Sloan Kettering Cancer Center), Luke Sikina(Dana-Farber Cancer Institute), Tali Mazor(Dana-Farber Cancer Institute), Xiang Li(Memorial Sloan Kettering Cancer Center), Angelica Ochoa(Memorial Sloan Kettering Cancer Center), Gaofei Zhao(Memorial Sloan Kettering Cancer Center), Bryan Lai(Memorial Sloan Kettering Cancer Center), Adam Abeshouse(Memorial Sloan Kettering Cancer Center), Diana Baiceanu(The Hyve (Netherlands)), Ersin Ciftci(Dana-Farber Cancer Institute), Uğur Doğrusöz(Bilkent University), Andrew Dufilie(Dana-Farber Cancer Institute), Ziya Erkoç(Bilkent University), Elena Garcia Lara(The Hyve (Netherlands)), Zhaoyuan Fu(Dana-Farber Cancer Institute), Benjamin E. Gross(Memorial Sloan Kettering Cancer Center), Charles Haynes(Children's Hospital of Philadelphia), Allison P. Heath(Children's Hospital of Philadelphia), David Higgins(Children's Hospital of Philadelphia), Prasanna Jagannathan(University Health Network), Karthik Kalletla(Children's Hospital of Philadelphia), Priti Kumari(Dana-Farber Cancer Institute), James Lindsay(Dana-Farber Cancer Institute), Aaron Lisman(Memorial Sloan Kettering Cancer Center), Bas Leenknegt(The Hyve (Netherlands)), Pieter Lukasse(The Hyve (Netherlands)), Divya Madela(Memorial Sloan Kettering Cancer Center), Ramyasree Madupuri(Memorial Sloan Kettering Cancer Center), Pim van Nierop(The Hyve (Netherlands)), Oleguer Plantalech(The Hyve (Netherlands)), Joyce Quach(Dana-Farber Cancer Institute), Adam Resnick(Children's Hospital of Philadelphia), Sander Y.A. Rodenburg(The Hyve (Netherlands)), Baby A. Satravada(Memorial Sloan Kettering Cancer Center), Fedde Schaeffer(The Hyve (Netherlands)), Robert L. Sheridan(Memorial Sloan Kettering Cancer Center), Jessica Singh(The Hyve (Netherlands)), Rajat Sirohi(Dana-Farber Cancer Institute), S. Onur Sumer(Memorial Sloan Kettering Cancer Center), Sjoerd van Hagen(The Hyve (Netherlands)), Avery Wang(Memorial Sloan Kettering Cancer Center), Manda Wilson(Memorial Sloan Kettering Cancer Center), Hongxin Zhang(Memorial Sloan Kettering Cancer Center), Kelsey Zhu(University Health Network), Nicole Rusk(Memorial Sloan Kettering Cancer Center), Samantha Brown(Memorial Sloan Kettering Cancer Center), Jessica A. Lavery(Memorial Sloan Kettering Cancer Center), Katherine S. Panageas(Memorial Sloan Kettering Cancer Center), Julia E. Rudolph(Memorial Sloan Kettering Cancer Center), Michele L. Lenoue-Newton(Vanderbilt University Medical Center), Jeremy L. Warner(Brown University), Xindi Guo(Sage Bionetworks), Haley Hunter-Zinck(Sage Bionetworks), Thomas Yu(Sage Bionetworks), Shirin Pilai(Memorial Sloan Kettering Cancer Center), Chelsea Nichols(Memorial Sloan Kettering Cancer Center), Stuart M. Gardos(Memorial Sloan Kettering Cancer Center), John Philip(Memorial Sloan Kettering Cancer Center), Kenneth L. Kehl(Dana-Farber Cancer Institute), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Deborah Schrag(Memorial Sloan Kettering Cancer Center), Jocelyn Lee(American Association For Cancer Research), Michael V. Fiandalo(American Association For Cancer Research), Shawn M. Sweeney(American Association For Cancer Research), Trevor J. Pugh(University Health Network), Chris Sander(Boston Medical Center), Ethan Cerami(Dana-Farber Cancer Institute), Jianjiong Gao(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center)
Cancer Research
September 5, 2023
Cited by 834Open Access
Full Text

Abstract

International cancer registries make real-world genomic and clinical data available, but their joint analysis remains a challenge. AACR Project GENIE, an international cancer registry collecting data from 19 cancer centers, makes data from >130,000 patients publicly available through the cBioPortal for Cancer Genomics (https://genie.cbioportal.org). For 25,000 patients, additional real-world longitudinal clinical data, including treatment and outcome data, are being collected by the AACR Project GENIE Biopharma Collaborative using the PRISSMM data curation model. Several thousand of these cases are now also available in cBioPortal. We have significantly enhanced the functionalities of cBioPortal to support the visualization and analysis of this rich clinico-genomic linked dataset, as well as datasets generated by other centers and consortia. Examples of these enhancements include (i) visualization of the longitudinal clinical and genomic data at the patient level, including timelines for diagnoses, treatments, and outcomes; (ii) the ability to select samples based on treatment status, facilitating a comparison of molecular and clinical attributes between samples before and after a specific treatment; and (iii) survival analysis estimates based on individual treatment regimens received. Together, these features provide cBioPortal users with a toolkit to interactively investigate complex clinico-genomic data to generate hypotheses and make discoveries about the impact of specific genomic variants on prognosis and therapeutic sensitivities in cancer. SIGNIFICANCE: Enhanced cBioPortal features allow clinicians and researchers to effectively investigate longitudinal clinico-genomic data from patients with cancer, which will improve exploration of data from the AACR Project GENIE Biopharma Collaborative and similar datasets.


Related Papers

No related papers found

Powered by citation graph analysis